Literature DB >> 22505724

Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.

Namrata D Udeshi1, D R Mani, Thomas Eisenhaure, Philipp Mertins, Jacob D Jaffe, Karl R Clauser, Nir Hacohen, Steven A Carr.   

Abstract

Ubiquitination plays a key role in protein degradation and signal transduction. Ubiquitin is a small protein modifier that is adducted to lysine residues by the combined function of E1, E2, and E3 enzymes and is removed by deubiquitinating enzymes. Characterization of ubiquitination sites is important for understanding the role of this modification in cellular processes and disease. However, until recently, large-scale characterization of endogenous ubiquitination sites has been hampered by the lack of efficient enrichment techniques. The introduction of antibodies that specifically recognize peptides with lysine residues that harbor a di-glycine remnant (K-ε-GG) following tryptic digestion has dramatically improved the ability to enrich and identify ubiquitination sites from cellular lysates. We used this enrichment technique to study the effects of proteasome inhibition by MG-132 and deubiquitinase inhibition by PR-619 on ubiquitination sites in human Jurkat cells by quantitative high performance mass spectrometry. Minimal fractionation of digested lysates prior to immunoaffinity enrichment increased the yield of K-ε-GG peptides three- to fourfold resulting in detection of up to ~3300 distinct K-GG peptides in SILAC triple encoded experiments starting from 5 mg of protein per label state. In total, we identify 5533 distinct K-ε-GG peptides of which 4907 were quantified in this study, demonstrating that the strategy presented is a practical approach to perturbational studies in cell systems. We found that proteasome inhibition by MG-132 and deubiquitinase inhibition by PR-619 induces significant changes to the ubiquitin landscape, but that not all ubiquitination sites regulated by MG-132 and PR-619 are likely substrates for the ubiquitin-proteasome system. Additionally, we find that the proteasome and deubiquitinase inhibitors studied induced only minor changes in protein expression levels regardless of the extent of regulation induced at the ubiquitin site level. We attribute this finding to the low stoichiometry of the majority ubiquitination sites identified in this study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505724      PMCID: PMC3418844          DOI: 10.1074/mcp.M111.016857

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  41 in total

1.  Degradation of some polyubiquitinated proteins requires an intrinsic proteasomal binding element in the substrates.

Authors:  Minglian Zhao; Nan-Yan Zhang; Ashley Zurawel; Kirk C Hansen; Chang-Wei Liu
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

2.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Authors:  K L Rock; C Gramm; L Rothstein; K Clark; R Stein; L Dick; D Hwang; A L Goldberg
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

3.  Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.

Authors:  Yong Ren; Jinghui Zhao; Jian Feng
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

4.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

5.  Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling.

Authors:  Guoqiang Xu; Jeremy S Paige; Samie R Jaffrey
Journal:  Nat Biotechnol       Date:  2010-07-18       Impact factor: 54.908

6.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips.

Authors:  Juri Rappsilber; Matthias Mann; Yasushi Ishihama
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.

Authors:  Mikael Altun; Holger B Kramer; Lianne I Willems; Jeffrey L McDermott; Craig A Leach; Seth J Goldenberg; K G Suresh Kumar; Rebecca Konietzny; Roman Fischer; Edward Kogan; Mukram M Mackeen; Joanna McGouran; Svetlana V Khoronenkova; Jason L Parsons; Grigory L Dianov; Benjamin Nicholson; Benedikt M Kessler
Journal:  Chem Biol       Date:  2011-11-23

8.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

9.  A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.

Authors:  Sebastian A Wagner; Petra Beli; Brian T Weinert; Michael L Nielsen; Jürgen Cox; Matthias Mann; Chunaram Choudhary
Journal:  Mol Cell Proteomics       Date:  2011-09-01       Impact factor: 5.911

10.  A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling.

Authors:  Nico P Dantuma; Tom A M Groothuis; Florian A Salomons; Jacques Neefjes
Journal:  J Cell Biol       Date:  2006-04-10       Impact factor: 10.539

View more
  78 in total

Review 1.  Characterizing ubiquitination sites by peptide-based immunoaffinity enrichment.

Authors:  Daisy Bustos; Corey E Bakalarski; Yanling Yang; Junmin Peng; Donald S Kirkpatrick
Journal:  Mol Cell Proteomics       Date:  2012-06-23       Impact factor: 5.911

2.  Using the ubiquitin-modified proteome to monitor protein homeostasis function.

Authors:  Andrea C Carrano; Eric J Bennett
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

3.  Eavesdropping on PTM cross-talk through serial enrichment.

Authors:  Kristofor Webb; Eric J Bennett
Journal:  Nat Methods       Date:  2013-07       Impact factor: 28.547

4.  Ubiquitin Chain Enrichment Middle-Down Mass Spectrometry (UbiChEM-MS) Reveals Cell-Cycle Dependent Formation of Lys11/Lys48 Branched Ubiquitin Chains.

Authors:  Ambar S J B Rana; Ying Ge; Eric R Strieter
Journal:  J Proteome Res       Date:  2017-08-07       Impact factor: 4.466

5.  A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.

Authors:  Haihui Lu; Karl R Clauser; Wai Leong Tam; Julia Fröse; Xin Ye; Elinor Ng Eaton; Ferenc Reinhardt; Vera S Donnenberg; Rohit Bhargava; Steven A Carr; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-09-28       Impact factor: 28.824

6.  Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma.

Authors:  Michael B Mann; Michael A Black; Devin J Jones; Jerrold M Ward; Christopher Chin Kuan Yew; Justin Y Newberg; Adam J Dupuy; Alistair G Rust; Marcus W Bosenberg; Martin McMahon; Cristin G Print; Neal G Copeland; Nancy A Jenkins
Journal:  Nat Genet       Date:  2015-04-13       Impact factor: 38.330

7.  ETD Outperforms CID and HCD in the Analysis of the Ubiquitylated Proteome.

Authors:  Tanya R Porras-Yakushi; Michael J Sweredoski; Sonja Hess
Journal:  J Am Soc Mass Spectrom       Date:  2015-05-21       Impact factor: 3.109

8.  The Histone Variant MacroH2A1 Is a BRCA1 Ubiquitin Ligase Substrate.

Authors:  Beom-Jun Kim; Doug W Chan; Sung Yun Jung; Yue Chen; Jun Qin; Yi Wang
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

9.  Serine 421 regulates mutant huntingtin toxicity and clearance in mice.

Authors:  Ian H Kratter; Hengameh Zahed; Alice Lau; Andrey S Tsvetkov; Aaron C Daub; Kurt F Weiberth; Xiaofeng Gu; Frédéric Saudou; Sandrine Humbert; X William Yang; Alex Osmand; Joan S Steffan; Eliezer Masliah; Steven Finkbeiner
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

10.  Ubiquitination of the scaffold protein IQGAP1 diminishes its interaction with and activation of the Rho GTPase CDC42.

Authors:  Laëtitia Gorisse; Zhigang Li; Craig D Wagner; David K Worthylake; Francesca Zappacosta; Andrew C Hedman; Roland S Annan; David B Sacks
Journal:  J Biol Chem       Date:  2020-02-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.